TCL Archive Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting April 29, 2011
TCL Archive FDA Announces Plan to Reform Drug Approval, Hire Outside Experts To Handel Some Reviews November 22, 1991
TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation April 17, 2009
TCL Archive 32% Rise In Breast Cancer Diagnosis In 1980s Explained By Increase In Mammography Screening September 21, 1990